As an organization that serves young women affected by breast cancer, we make sure to keep up with the latest news so we know what our women face when it comes to treatment and beyond. In this blog series, we will share the month’s news that we feel is most interesting and relevant.
October 2: Deaths from breast cancer are still declining in the United States, even as more women are being diagnosed with the disease, a new report shows. Read more about these new statistics HERE in HealthDay.
October 11: Researchers at Mayo Clinic in Jacksonville, Florida say a vaccine they have developed could be available within eight years that may not only stop the recurrence of breast and ovarian cancers, but prevent them from developing in the first place. Immunologists at Mayo already have two cancer vaccines against Triple Negative Breast Cancer and HER2 Positive Breast Cancer, respectively. They’re also working on a third against ductal carcinoma in situ, or DCIS, a noninvasive breast cancer. Read the full story in Forbes HERE.
October 22: Men with breast cancer are more likely to die than their female counterparts, across all stages of disease, with the disparity persisting even when clinical characteristics, such as cancer types, treatment and access to care are considered, according to a new study. Read the story in Science Daily HERE.
October 22: Women diagnosed with breast cancer between two routine screenings have an increased risk for other types of cancer, according to a new study. Breast cancer detected between two routine screenings is called interval cancer, and it tends to be more advanced, more aggressive and to have a worse prognosis than cancers found during screenings. Read more in a HealthDay article HERE.
October 23: The US Food and Drug Administration recommended a “boxed warning” on labeling materials for breast implants. Boxed warnings, which alert health care providers and consumers to serious risks associated with a drug or device, are the strongest form of warning required by the FDA for labeling. (The FDA offered the recommendation for public comment and review as a draft guidance; it is not yet finalized.) Read the story on CNN HERE.
October 28: Drugs can be safely delivered to cancerous lymph nodes via the lymphatic system and then released inside the nodes using sound waves. Researchers tested the treatment on mice with metastatic breast cancer. Read more in the Science Daily article HERE.